Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

por Kaffash Farkhad, Najmeh, Sedaghat, Alireza, Reihani, Hamidreza, Adhami Moghadam, Amir, Bagheri Moghadam, Ahmad, Khadem Ghaebi, Nayereh, Khodadoust, Mohammad Ali, Ganjali, Rashin, Tafreshian, Amir Reza, Tavakol-Afshari, Jalil
Publicado 2022